RxDoctor Payments Data

William Newell, MD

Physical Medicine & Rehabilitation · Newark, DENPI 1992971055

Payments from drug & device makers

What this record shows

Boston Scientific accounts for 80.9% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $1,089 and has fallen 79.6% since, to $222 in 2025.

$1,547in general payments, 2019–2025

Across 38 payments — averaging $40.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • Abbott$269
  • Medtronic$26

What the payments were for

  • Travel & lodging$75149%
  • Food & beverage$79751%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific26$1,252
Abbott11$269
Medtronic1$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,547 in reported general payments places this provider in the 65th percentile of 32 physical medicine & rehabilitation providers in Delaware.

See all physical medicine & rehabilitation providers in Delaware

Medicare billing

Part B allowed, 2024
$254,854
Medicare patients
746
Services billed
2,511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin248$3,107
Tramadol Hcl112$509
Methylprednisolone78$468
Cyclobenzaprine Hcl20$285
Tizanidine Hcl27$219
Meloxicam51$205
Acetaminophen-CodeineAcetaminophen With Codeine18$168
Alprazolam46$40

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →